Comparison of the Effect of Age (< 75 Versus >= 75) on the Efficacy and Safety of Dual Therapy (Dabigatran plus Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin plus Aspirin plus Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUAL PCI Trial)



ten Berg, Jurrien M, Steg, Philippe Gabriel, Bhatt, Deepak L, Hohnloser, Stefan H, de Veer, Anne, Nordaby, Matias, Miede, Corinna, Kimura, Takeshi, Lip, Gregory YH ORCID: 0000-0002-7566-1626, Oldgren, Jonas
et al (show 2 more authors) (2020) Comparison of the Effect of Age (< 75 Versus >= 75) on the Efficacy and Safety of Dual Therapy (Dabigatran plus Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin plus Aspirin plus Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUAL PCI Trial). AMERICAN JOURNAL OF CARDIOLOGY, 125 (5). 735 - 743.

Access the full-text of this item by clicking on the Open Access link.
Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 12 Feb 2020 12:14
Last Modified: 09 Jan 2021 02:26
DOI: 10.1016/j.amjcard.2019.11.029
Open Access URL: https://doi.org/10.1016/j.amjcard.2019.11.029
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3074685